Servier Symphogen A/S

The financial health of Servier Symphogen A/S appears to be improving, with a notable increase in revenue and profit over the past two years. In 2024, the company reported revenue of 474.7 million DKK and a profit of 37.3 million DKK, following a revenue of 471.5 million DKK and a profit of 49.1 million DKK in 2023. Despite a significant profit dip in 2022, where it recorded a profit of 165.7 million DKK on lower revenue, the overall trend shows recovery and growth. A key concern remains its equity position, which has improved to 223.7 million DKK in 2024 from a negative equity of -115.3 million DKK in 2020, indicating a recovery from previous financial distress. As a player in the research and experimental development sector, the company is positioned to leverage its recent financial improvements for future growth.

AI-generated summary